Article
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT.
American journal of hematology - 1 Jul 2017
Canaani Jonathan, Labopin Myriam, Socié Gerard, Nihtinen Anne, Huynh Anne, Cornelissen Jan, Deconinck Eric, Gedde-Dahl Tobias, Forcade Edouard, Chevallier Patrice, Bourhis Jean H, Blaise Didier, Mohty Mohamad, Nagler Arnon
Abstract excerpt
Up to 20% of acute myeloid leukemia (AML) patients present initially with hyperleukocytosis, placing them at increased risk for early mortality during induction. Yet, it is unknown whether hyperleukocytosis still retains prognostic value for AML patients undergoing hematopoietic stem cell transplantation (HSCT). Furthermore, it is unknown whether hyperleukocytosis holds prognostic significance when modern...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.